摘要
[目的]总结浙江省名中医舒琦瑾教授临证治疗肺癌的常用药对机制。[方法]跟随舒琦瑾教授临诊学习,搜集舒琦瑾教授的肺癌医案,总结其临证治疗肺癌的用药规律和常用药对,并探讨其机制,并附验案1则。[结果]舒师认为,中医药治疗肺癌属于多靶点疗法,药对虽短小,肺癌病机亦复杂,然对药对于肺癌某个靶点的针对性强,若组合恰当,定能执简化繁,明察洞悉。针对肺癌晚期患者出现的正气不足症状,舒师常用太子参-黄芪、党参-白术、北沙参-麦冬等药对以扶正抗癌;属痰毒互结者,舒师常用蛇舌草-蛇六谷、半边莲-半枝莲、南方红豆杉-虎杖根等药对以解毒散结;属瘀血内阻者,舒师常用三棱-莪术、三七-赤芍等药对以活血祛瘀。舒师临证治疗肺癌时,在辨证论证的基础上,辨明病因、病位、病性、病势,并掌握中药的四气五味、升降浮沉,运用药对,临证加减,遣方用药,取得较好的临床疗效。[结论]舒师运用药对精当,疗效确定,其用药机制有较高临床参考价值,值得深入学习和推广运用。
Objective] To summarize the experiences of Professor Shu Qijin and to introduce his frequently used traditional Chinese medicine(TCM) herbal-pairs for treating lung cancer. [Methods] Professor Shu's experience and the treatment principles on herbal-pairs were summarized by attending the process of his diagnosis and treatment for lung cancer patients and his medical records. [Results] Shu treated that lung cancer by traditional Chinese medicine belongs to the multi-target therapy, drug although short, lung disease is also complex. However, the drug for lung cancer a target in strong, if properly combined, can hold simplification, observant insight. For advanced lung cancer patients with Qi deficiency symptoms, Shu used common heterophylla-Astragalus, Codonopsis-white atractylodes rhizome, Radix Glehniae, Ophiopogon japonicus, medicine of Fuzheng anticancer; sputum is a poison stasis, Shu divided common diffusa-sheliugu, Lobelia chinensis, Scutellaria barbata, Taxus chinensis var. mairei, Polygonum cuspidatum root medicine for detoxification Sanjie; blood stasis, Shu used common trigonous, rhizome, notoginseng, radix paeoniae rubra, etc. drug for promoting blood circulation and removing blood stasis. Anyway, Shu permited the treatment of lung cancer, on the basis of dialectical argumentation, discerning the pathogeny, disease location, disease, illness and mastering five flavors of the four properties of traditional Chinese medicine(TCM), rising and sinking, using the following drugs, clinical addition and subtraction, herbal prescription has better clinical efficacy, and attached with the case of a post-mortem. [Conclusions]Medicine of precise curative effect is determined by Shu and the mechanism of medication has higher clinical value,it is worth in-depth study and application.
出处
《浙江中医药大学学报》
CAS
2016年第3期200-203,共4页
Journal of Zhejiang Chinese Medical University
关键词
肺癌
舒琦瑾
药对
配伍
用药规律
临证经验
学术传承
lung cancer
Shu Qijin
herbal-pairs
compatibility
drug regulation
clinical experience
academic inheritance